Grapevine: TPG, others in race for pharma deal; NIIF's road portfolio on the block

By Shubhobrota Dev Roy

  • 19 Oct 2023
Premium
A screen announces the listing of TPG at the Nasdaq Market site in Times Square, New York City, Jan. 13, 2022. | Credit: Reuters/Brendan McDermid

Multiple private equity players including Apax Partners, TPG Capital, TA Associates and Kedaara Capital are in early talks to buy a Mumbai-based pharma company that makes oral dosage formulations on contract manufacturing basis, a media report has said.  The investors are looking to acquire Inventia Healthcare at a valuation of Rs ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.